Evaxion A (EVAX) Return on Equity [ROE] (2021 - 2026)
Evaxion A (EVAX) recorded Return on Equity [ROE] of -89.12% in Q2 2026, up 55.43 percentage points from -144.55% a year earlier but down 14.84 percentage points from the prior quarter.
Powered by 
Analysis
Evaxion A (EVAX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Evaxion A reported Return on Equity [ROE] of -100.18%.
- Annual Return on Equity [ROE] has a five-year change of +82.97 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -1238.11% in FY2023 (-1124.37 pp), -113.74% in FY2022 (-32.29 pp) and -81.45% in FY2021 (+101.69 pp).
- Quarterly Return on Equity [ROE] has ranged from -1727.51% in Q3 2024 to -52.04% in Q4 2025 over the past five years.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 1675.34 percentage points in Q3 2025, against a drop of 249.78 percentage points in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -74.28% (Q1 2026), -52.04% (Q4 2025) and -52.16% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.66% |
| 10 | Evaxion A | 17.56 Mn | -48.69 Mn | - | -89.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -89.12% |
| Mar 31, 2026 | -74.28% |
| Dec 31, 2025 | -52.04% |
| Sep 30, 2025 | -52.16% |
| Jun 30, 2025 | -144.55% |
| Mar 31, 2025 | -307.03% |
| Sep 30, 2024 | -1,727.51% |
| Jun 30, 2024 | -788.44% |
| Jun 30, 2023 | -538.66% |
| Mar 31, 2023 | -317.53% |
| Dec 31, 2022 | -268.22% |
| Sep 30, 2022 | -164.29% |
| Jun 30, 2022 | -253.57% |
| Mar 31, 2022 | -160.62% |
| Sep 30, 2021 | -104.85% |
| Jun 30, 2021 | -74.80% |
| Mar 31, 2021 | -85.21% |
API Access
Evaxion A Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();